ClinicalTrials.Veeva

Menu

Fluid Status and T1-mapping by CMR (BCM-CMR-T1)

Medical University of Vienna logo

Medical University of Vienna

Status

Unknown

Conditions

Valvular Heart Disease
Heart Failure
Heart Diseases

Treatments

Diagnostic Test: Bioimpedance spectroscopy

Study type

Observational

Funder types

Other

Identifiers

NCT03372512
BCM-CMR-T1

Details and patient eligibility

About

It is unclear to what extent systemic fluid overload has an impact on T1-mapping results by cardiovascular mangetic resonance imaging.

In this study, patients will undergo body composition monitoring assessing systemic fluid overload and T1-mapping using MOLLI by cardiovacular magnetic resonance imaging in order to investigate a possible association with each other.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • written informed consent
  • patient undergoing cardiovascular magnetic resonance imaging

Exclusion criteria

  • Unwillingness to participate
  • pregnancy

Trial design

200 participants in 2 patient groups

Fluid overload (Liters) ≥ median
Treatment:
Diagnostic Test: Bioimpedance spectroscopy
Fluid overload (Liters) < median
Treatment:
Diagnostic Test: Bioimpedance spectroscopy

Trial contacts and locations

1

Loading...

Central trial contact

Andreas Kammerlander, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems